Tilman Gerlach
Autoimmunhepatitis
Sulz M, Gerlach T. Autoimmunhepatitis - So diagnostizieren und behandeln Sie richtig. Hausarztpraxis 2013:10-14.
Dec 10, 2013Autoimmunhepatitis
Dec 10, 2013Hausarztpraxis 2013:10-14
Sulz Michael, Gerlach Tilman
[Autoimmune hepatitis]
Sulz M, Gerlach T. [Autoimmune hepatitis]. Ther Umsch 2011; 68:189-94.
Apr 1, 2011[Autoimmune hepatitis]
Apr 1, 2011Ther Umsch 2011; 68:189-94
Sulz Michael, Gerlach Tilman
FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C
Heeg M, Spannagl M, Kauke T, Horster S, Schraut W, Raziorrouh B, Gerlach T, Jung M, Zachoval R, Grüner N, Ulsenheimer A, Diepolder H. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C. Gastroenterology 2009; 137:1280-8.e1-6.
Oct 1, 2009FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C
Oct 1, 2009Gastroenterology 2009; 137:1280-8.e1-6
Heeg Malte H J, Spannagl Michael, Kauke Teresa, Horster Sophia, Schraut Winfried, Raziorrouh Bijan, Gerlach Tilman, Jung Maria-Christina, Zachoval Reinhart, Grüner Norbert H, Ulsenheimer Axel, Diepolder Helmut M
Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients
Berg T, Sarrazin C, Neumann K, Zankel M, Balk H, Buggisch P, Spengler U, Gerlach T, Hinrichsen H, Rasenack J, Möller B, Klinker H, Teuber G, Weich V, Zeuzem S. Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients. Hepatology (Baltimore, Md.) 2009; 50:369-77.
Aug 1, 2009Individualized treatment strategy according to early viral kinetics in hepatitis C virus type 1-infected patients
Aug 1, 2009Hepatology (Baltimore, Md.) 2009; 50:369-77
Berg Thomas, Sarrazin Christoph, Neumann Konrad, Zankel Myrga, Balk Heike, Buggisch Peter, Spengler Ulrich, Gerlach Tilman, Hinrichsen Holger, Rasenack Jens, Möller Bernd, Klinker Hartwig, Teuber Gerlinde, Weich Viola, Zeuzem Stefan
Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany
Dintsios C, Haverkamp A, Wiegand J, Gerlach T, Wedemeyer H, Pape G, Manns M, Krauth C. Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany. European journal of gastroenterology & hepatology 2009
Jun 22, 2009Economic evaluation of early monotherapy versus delayed monotherapy or combination therapy in patients with acute hepatitis C in Germany
Jun 22, 2009European journal of gastroenterology & hepatology 2009
Dintsios Charalabos-Markos, Haverkamp Alexander, Wiegand Johannes, Gerlach Tilman, Wedemeyer Heiner, Pape Gerd, Manns Michael, Krauth Christian
Acute hepatitis C: current status and remaining challenges
Santantonio T, Wiegand J, Gerlach T. Acute hepatitis C: current status and remaining challenges. Journal of hepatology 2008; 49:625-33.
Oct 1, 2008Acute hepatitis C: current status and remaining challenges
Oct 1, 2008Journal of hepatology 2008; 49:625-33
Santantonio Teresa, Wiegand Johannes, Gerlach Tilman
Antigen kinetics determines immune reactivity
Johansen P, Bot A, Speck R, Gerlach T, Mullhaupt B, Senti G, Lang K, Manolova V, Smith K, Der-Sarkissian A, Qiu Z, Rettig L, Storni T, Kündig T. Antigen kinetics determines immune reactivity. Proceedings of the National Academy of Sciences of the United States of America 2008; 105:5189-94.
Apr 1, 2008Antigen kinetics determines immune reactivity
Apr 1, 2008Proceedings of the National Academy of Sciences of the United States of America 2008; 105:5189-94
Johansen Pål, Bot Adrian, Speck Roberto F, Gerlach Tilman, Mullhaupt Beat, Senti Gabriela, Lang Karl S, Manolova Vania, Smith Kent A, Der-Sarkissian Ani, Qiu Zhiyong, Rettig Lorna, Storni Tazio, Kündig Thomas M
Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT
Wildi S, Gubler C, Hany T, Petrowsky H, Clavien P, Jochum W, Gerlach T, Fried M, Mullhaupt B. Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT. Journal of clinical ultrasound : JCU 2008; 36:20-6.
Jan 1, 2008Intraoperative sonography in patients with colorectal cancer and resectable liver metastases on preoperative FDG-PET-CT
Jan 1, 2008Journal of clinical ultrasound : JCU 2008; 36:20-6
Wildi Stephan M, Gubler Christoph, Hany Thomas, Petrowsky Henrik, Clavien Pierre A, Jochum Wolfram, Gerlach Tilman, Fried Michael, Mullhaupt Beat
Hot topics in liver transplantation: organ allocation--extended criteria donor--living donor liver transplantation
Mullhaupt B, Dimitroulis D, Gerlach T, Clavien P. Hot topics in liver transplantation: organ allocation--extended criteria donor--living donor liver transplantation. Journal of hepatology 2008; 48 Suppl 1:S58-67.
Jan 1, 2008Hot topics in liver transplantation: organ allocation--extended criteria donor--living donor liver transplantation
Jan 1, 2008Journal of hepatology 2008; 48 Suppl 1:S58-67
Mullhaupt Beat, Dimitroulis Dimitrios, Gerlach Tilman, Clavien Pierre-Alain
Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial
Kronenberger B, Hopf U, Pape G, Wursthorn K, Nasser S, Goeser T, Spengler U, Buggisch P, Gerlach T, Hinrichsen H, Herrmann E, Berg T, Zeuzem S. Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial. European journal of gastroenterology & hepatology 2007; 19:639-46.
Aug 1, 2007Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial
Aug 1, 2007European journal of gastroenterology & hepatology 2007; 19:639-46
Kronenberger Bernd, Hopf Uwe, Pape Gerd R, Wursthorn Karsten, Nasser Samer, Goeser Tobias, Spengler Ulrich, Buggisch Peter, Gerlach Tilman, Hinrichsen Holger, Herrmann Eva, Berg Thomas, Zeuzem Stefan
13C-methacetin breath test as a quantitative liver function test in patients with chronic hepatitis C infection: continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry
Goetze O, Selzner N, Fruehauf H, Fried M, Gerlach T, Mullhaupt B. 13C-methacetin breath test as a quantitative liver function test in patients with chronic hepatitis C infection: continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry. Alimentary pharmacology & therapeutics 2007; 26:305-11.
Jul 15, 200713C-methacetin breath test as a quantitative liver function test in patients with chronic hepatitis C infection: continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry
Jul 15, 2007Alimentary pharmacology & therapeutics 2007; 26:305-11
Goetze O, Selzner N, Fruehauf H, Fried M, Gerlach Tilman, Mullhaupt B
Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine
Gruener N, Gerlach T, Ulsenheimer A, Diepolder H, Wierenga E, Zachoval R, Heeg M, Pape G, Jung M. Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine. Vaccine 2007; 25:4960-6.
Jun 21, 2007Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine
Jun 21, 2007Vaccine 2007; 25:4960-6
Gruener Norbert H, Gerlach Tilman, Ulsenheimer Axel, Diepolder Helmut M, Wierenga Eddy, Zachoval Reinhart, Heeg Malte, Pape Gerd Rudolf, Jung Maria-Christina
Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection
Lucas M, Santantonio T, Fidler S, Thimme R, Haberstroh A, Baumert T, Klenerman P, Diepolder H, Nitschko H, Obermeier M, Phillips R, Scriba T, Semmo N, Day C, Weber J, Schraut W, Pape G, Zachoval R, Ulsenheimer A, Pfafferot K, Heeg M, Gaudieri S, Grüner N, Rauch A, Gerlach T, Jung M. Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection. PloS one 2007; 2:e649.
Jan 1, 2007Tracking virus-specific CD4+ T cells during and after acute hepatitis C virus infection
Jan 1, 2007PloS one 2007; 2:e649
Lucas Michaela, Santantonio Teresa, Fidler Sarah, Thimme Robert, Haberstroh Anita, Baumert Thomas F, Klenerman Paul, Diepolder Helmut M, Nitschko Hans, Obermeier Martin, Phillips Rodney, Scriba Thomas J, Semmo Nasser, Day Cheryl, Weber Jonathan N, Schraut Winfried, Pape Gerd R, Zachoval Reinhart, Ulsenheimer Axel, Pfafferot Katja, Heeg Malte H J, Gaudieri Silvana, Grüner Norbert, Rauch Andri, Gerlach Tilman, Jung Maria-Christina
Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses
Ulsenheimer A, Diepolder H, Wucherpfennig K, Pape G, Loughry A, Gruener N, Gerlach T, Seth N, Lucas M, Klenerman P. Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses. Journal of viral hepatitis 2006; 13:708-14.
Oct 1, 2006Transient immunological control during acute hepatitis C virus infection: ex vivo analysis of helper T-cell responses
Oct 1, 2006Journal of viral hepatitis 2006; 13:708-14
Ulsenheimer A, Diepolder H M, Wucherpfennig K W, Pape G R, Loughry A, Gruener N H, Gerlach Tilman, Seth N P, Lucas M, Klenerman P
Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin
Berg T, Alshuth U, Martus P, Spengler U, Klinker H, Kallinowski B, Schmidt W, Pape G, Rasenack J, Goeser T, Buggisch P, Gerlach T, Heintges T, Sarrazin C, Nasser S, von Wagner M, Zeuzem S. Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin. Gastroenterology 2006; 130:1086-97.
Apr 1, 2006Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin
Apr 1, 2006Gastroenterology 2006; 130:1086-97
Berg Thomas, Alshuth Ulrich, Martus Peter, Spengler Ulrich, Klinker Hartwig, Kallinowski Birgit, Schmidt Wolfgang E, Pape Gerd R, Rasenack Jens, Goeser Tobias, Buggisch Peter, Gerlach Tilman, Heintges Tobias, Sarrazin Christoph, Nasser Samer, von Wagner Michael, Zeuzem Stefan
Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins
Gerlach T, Pape G, Zachoval R, Vogler A, Zahn R, Witter K, Scholz S, Heeg M, Schirren C, Schraut W, Jung M, Grüner N, Ulsenheimer A, Diepolder H. Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins. Journal of virology 2005; 79:12425-33.
Oct 1, 2005Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins
Oct 1, 2005Journal of virology 2005; 79:12425-33
Gerlach Tilman, Pape G R, Zachoval R, Vogler A, Zahn R, Witter K, Scholz S, Heeg M, Schirren C-A, Schraut W, Jung M-C, Grüner N H, Ulsenheimer A, Diepolder H M
Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment
Backmund M, Reimer J, Meyer K, Gerlach T, Zachoval R. Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005; 40 Suppl 5:S330-5.
Apr 15, 2005Hepatitis C virus infection and injection drug users: prevention, risk factors, and treatment
Apr 15, 2005Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005; 40 Suppl 5:S330-5
Backmund Markus, Reimer Jens, Meyer Kirsten, Gerlach Tilman, Zachoval Reinhart
Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection
Ulsenheimer A, Pape G, Zachoval R, Schirren C, Heeg M, Schraut W, Santantonio T, Backmund M, Wächtler M, Gruener N, Jung M, Gerlach T, Diepolder H. Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection. Hepatology (Baltimore, Md.) 2005; 41:643-51.
Mar 1, 2005Plasmacytoid dendritic cells in acute and chronic hepatitis C virus infection
Mar 1, 2005Hepatology (Baltimore, Md.) 2005; 41:643-51
Ulsenheimer Axel, Pape Gerd R, Zachoval Reinhart, Schirren Carl A, Heeg Malte H J, Schraut Winfried, Santantonio Teresa, Backmund Markus, Wächtler Martin, Gruener Norbert, Jung Maria-Christina, Gerlach Tilman, Diepolder Helmut M
Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation
Gruener N, Pape G, Schauer R, Baretton G, Diepolder H, Zachoval R, Gerlach T, Ulsenheimer A, Jung M, Schirren C. Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004; 10:1487-96.
Dec 1, 2004Analysis of a successful HCV-specific CD8+ T cell response in patients with recurrent HCV-infection after orthotopic liver transplantation
Dec 1, 2004Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2004; 10:1487-96
Gruener Norbert Hubert, Pape Gerd Rudolf, Schauer Rolf, Baretton Gustavo, Diepolder Helmut Michael, Zachoval Reinhart, Gerlach Tilman, Ulsenheimer Axel, Jung Maria-Christina, Schirren Carl Albrecht
Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C
Steinmann D, Blum H, Liang T, Inchauspé G, Patel A, Maertens G, Jacobs D, Depla E, Pape G, Gerlach T, Adah M, Schürmann P, Gissler B, Barth H, Baumert T. Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C. Journal of virology 2004; 78:9030-40.
Sep 1, 2004Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C
Sep 1, 2004Journal of virology 2004; 78:9030-40
Steinmann Daniel, Blum Hubert E, Liang T Jake, Inchauspé Geneviève, Patel Arvind H, Maertens Geert, Jacobs Dirk, Depla Erik, Pape Gerd R, Gerlach Tilman, Adah Mohammed I, Schürmann Peter, Gissler Bettina, Barth Heidi, Baumert Thomas F